Member Info for Chelsea11

Personally I also don’t pay much attention to what the Company puts on LinkedIn re trials. It’s only ever a regurgitation of news published via RNS, which of course every existing investor should already know and any prospective investor should be following closely.

There is zero to read into those statements imo.

The point I was previously making about the Divi, was that there IS a Divi and it is also very decent and therefore one of the good reasons to invest / top-up / average down here when the SP was c.40p, as opposed to a share investment with NO Divi.

This very easy to understand point got lost in a smokescreen and twisted into nonsense that the point raised meant a lack of understanding that an SP will usually retreat when ex-divi.

Couerdelion - your question was directed to Ironknut, no one else, as was my response to yours.

Maybe we’ll get a reply?

Yep would love to hear a structured and coherent response to that question.

But not expecting one.

An interesting recent article……….

https://www.rokoko.com/insights/will-generative-ai-replace-motion-capture-in-2026

I think suggesting the BoD are keen to “pump” the SP is an unfortunate phrase.

Trumpsky - you’ve been unmasked here as someone who has such a fragile ego, that it leads you to your feeble attempts to distort reality. Your psychological constitution is so brittle that admitting you made a mistake, or that you were wrong is fundamentally too threatening for your vast ego to tolerate. This is now crystal clear to anyone reading your posts.

Back on filter you go, to save you further embarrassment. I might decide to unfilter you at 70p later this year 🤣

Today’s price action was absolutely nothing to to with Faron imo. Some folks (or maybe even one person) decided to sell and then after that some folks decided to buy, including at least two holders here.

Relax. Cadbury’s Caramel.

Trumpsky - where have I said that going ex-dividend will have no impact on the share price?

What I said was the dividend payment due to be paid in the near future was “another win for anyone who had bought in here / topped up / averaged down” and any investor here with more than 1 brain cell can appreciate that is not the same as saying “going ex-dividend will have no impact on the share price”

🤣

AGM will be held on 25/02 and so it follows that any AGM Statement will very likely be within a 7am RNS on that day.

Just a couple of weeks to wait for that.

Yep and of course another win for anyone who had bought in here / topped up / averaged down.

Very positive step in the growth of the company and looks like a bargain price.

https://www.parkland.com.au/

Yeah that’s interesting JB1.

GEN1079 hasn’t yet made it onto the Pipeline page at the Genmab website but when it does, it will list any partner they are working with. See GEN1059 which shows BioNTech as an example.

https://www.genmab.com/antibody-science/pipeline

Berms helpful post also ties in with what I dug up on the different timelines between FDA approval and EMA. Note the conclusion at the end of the publication and also that it’s come from ASCO so I’d assume this is accurate information (it’s also backed up by more recent articles from other sources).

https://ascopubs.org/doi/10.1200/JCO.2021.39.15_suppl.1575

Caveat - this is very old but you will understand why I’ve posted it in context of my previous post.

https://www.stuff.co.nz/waikato-times/4099716/Go-getting-Kiwi-scientist-makes-good-in-the-UK

HAGW x2

I’ve always thought (and said here previously) that New Zealand could be a potential trial location, given Melanoma numbers but also PLH background and connection there.

HAGW.

Yes thanks SML.

I managed to read without subscription to IC. Very positive and no doubt you are right about it being the reason for volume today.

https://www.investorschronicle.co.uk/content/24a4bbe6-7cd1-4825-923c-008a2c39fbc1#:~:text=Venture%20Life%20received%20cash%20proceeds,first%20year%20under%20new%20ownership.

Interesting isn’t it, especially on a Friday.

It may not be the reason for today’s rise but I anticipate some M&A news this quarter. It was signposted in the January Trading Update imo.

DaveV - 41.5p WAS exceptionally good value. The advice offered here to me, you and anyone else that bought in at that level recently, was that it was foolish and stupid. Scroll back just a few posts and those exact words used are there in black and white.

(Expect another monster post here shortly, banging on again about other shares (like he thinks no one else has a diversified portfolio with other shares doing nicely), how terrible Imogen is on repeat etc etc., all by intention a vast cloud of smoke to cover up that he called THIS SHARE totally wrong).

Cutting through the deliberate smog of ginormous posts to hide the outcome, we got there in the end.

Started just a few weeks ago with “a fool and his money are easily parted” and that averaging down here was a “stupid strategy”. Followed yesterday by “ I'd agree that investing in OMG in the mid-40s has proven a sound decision”. All quotes and so a candid admission that what was said weeks ago was hog and very poor investment advice.

Btw, that wasn’t just me Trumpsky was calling a fool and stupid. It was EVERYONE here who believed the share had been oversold and had the confidence to back the Company at circa 40p.